FOMX
Barclays’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-39
| Closed | – | – | 4096 |
|
|
2019
Q4 | $0 | Sell |
39
-1,088
| -97% | – | ﹤0.01% | 4469 |
|
|
2019
Q3 | $3K | Buy |
+1,127
| New | +$3K | ﹤0.01% | 3993 |
|
|
2019
Q2 | – | Sell |
-1,124
| Closed | -$4K | – | 4585 |
|
|
2019
Q1 | $4K | Buy |
1,124
+407
| +57% | +$1.45K | ﹤0.01% | 4111 |
|
|
2018
Q4 | $3K | Sell |
717
-6,749
| -90% | -$28.2K | ﹤0.01% | 3891 |
|
|
2018
Q3 | $43K | Sell |
7,466
-13,180
| -64% | -$75.9K | ﹤0.01% | 3780 |
|
|
2018
Q2 | $104K | Sell |
20,646
-96,750
| -82% | -$487K | ﹤0.01% | 3050 |
|
|
2018
Q1 | $602K | Buy |
117,396
+110,801
| +1,680% | +$568K | ﹤0.01% | 2156 |
|
|
2017
Q4 | $40K | Buy |
+6,595
| New | +$40K | ﹤0.01% | 3432 |
|
|
2017
Q3 | – | Sell |
-149
| Closed | -$1K | – | 4221 |
|
|
2017
Q2 | $1K | Hold |
149
| – | – | ﹤0.01% | 3813 |
|
|
2017
Q1 | $1K | Sell |
149
-1,107
| -88% | -$7.43K | ﹤0.01% | 3975 |
|
|
2016
Q4 | $14K | Sell |
1,256
-261,280
| -100% | -$2.91M | ﹤0.01% | 3197 |
|
|
2016
Q3 | $2.43M | Buy |
262,536
+259,741
| +9,293% | +$2.41M | ﹤0.01% | 987 |
|
|
2016
Q2 | $17K | Sell |
2,795
-663
| -19% | -$4.03K | ﹤0.01% | 2863 |
|
|
2016
Q1 | $21K | Buy |
3,458
+2,921
| +544% | +$17.7K | ﹤0.01% | 2775 |
|
|
2015
Q4 | $4K | Buy |
537
+419
| +355% | +$3.12K | ﹤0.01% | 2957 |
|
|
2015
Q3 | $1K | Sell |
118
-6,015
| -98% | -$51K | ﹤0.01% | 3836 |
|
|
2015
Q2 | $61K | Buy |
+6,133
| New | +$61K | ﹤0.01% | 2550 |
|
|
2014
Q4 | – | Sell |
-5,700
| Closed | -$29K | – | 4419 |
|
|
2014
Q3 | $29K | Buy |
+5,700
| New | +$29K | ﹤0.01% | 3249 |
|